AGENUS INC

AGEN ·Healthcare, Drug Manufacturers - General, United States
Financial Statements Income Statement
Annual Quarterly

Income Statement

Line Item Aug 2026 Jun 2026 May 2026 Mar 2026 Mar 2026 Dec 2025 Nov 2025 Sep 2025
Revenue $34.5M $33.7M $30.2M
Cost of Revenue $0 $0 $642.0K
Gross Profit $34.5M $33.7M $29.6M
Gross Margin 100.0% 100.0% 97.9%
Operating Expenses
Research & Development $14.8M $11.8M $23.6M
SG&A Expense $8.5M $6.9M $10.9M
Operating Income $11.3M $15.1M $-4.5M
Operating Margin 32.7% 44.6% -15.0%
Interest Expense
Pretax Income
Income Tax Expense
Net Income $-567.0K $39.2M $63.9M
Net Margin -1.6% 116.2% 211.4%
EPS (Basic) $-0.01 $1.03 $2.00
EPS (Diluted) $-0.01 $1.02 $1.94
Shares Outstanding (Basic) 45.0M 41.3M 41.6M 37.9M 38.4M 35.3M 34.0M 31.9M
Shares Outstanding (Diluted) 45.0M 41.3M 41.6M 38.3M 38.4M 35.3M 34.0M 32.9M
Dividends Per Share
← Newer Page 1 of 16 Older →